Supporting Patients With Untreated Prostate Cancer on Active Surveillance: What Causes an Increase in Anxiety During the First 10 Months?

Frontiers in Psychology

article

Maria Francesca Alvisi¹  Julia Menichetti¹  Villa Silvia¹  Zollo Fabiana¹  Salvioni Roberto²  Valdagni Riccardo¹  Bellardita Lara¹  Paola Dordoni¹  Tiziana Rancati¹  Barbara Avuzzi¹  Nicola Nicolai²  Fabio Badenchini¹  Letizia De Luca¹  Tiziana Magnani¹  Cristina Marenghi¹ 

[1] Prostate Cancer Program, Fondazione IRCCS Istituto Nazionale dei Tumori;Department of Urology, Fondazione IRCCS Istituto Nazionale dei Tumori;Department of Oncology and Hemato-Oncology, University of Milan

关键词: anxiety;    active surveillance;    prostate cancer;    coping strategies;    personality traits;   

DOI  :  10.3389/fpsyg.2020.576459

学科分类：社会科学、人文和艺术（综合）

来源: Frontiers

【 摘 要 】

Background The psychological burden possibly deriving from not immediately undergoing radical treatment for prostate cancer (PCa) could be a potential disadvantage of active surveillance (AS), especially in the eve of some relevant clinical exams [i.e., re-biopsy, prostate-specific antigen (PSA) test, and medical examination]. Even if it is known from the literature that the majority of PCa men in AS do not report heightened anxiety, there is a minority of patients who show clinically significant levels of anxiety after diagnosis. The present study aimed to investigate if demographic, clinical, and psychological variables at the entrance in AS (T0) were associated with the risk of developing clinically significant PCa-related anxiety 2 months before the first re-biopsy (T1) and to offer psychological support to improve quality of life (QoL).

【 授权许可】

CC BY